CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Solarvest Bioenergy Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Solarvest Bioenergy Inc
301 - 1228 Hamilton Street
Phone: (604) 684-3323p:604 684-3323 VANCOUVER, BC  V6B 6L2  Canada Ticker: SVS.HSVS.H
Business Summary
Solarvest BioEnergy Inc. is a Canada-based algae biologic company with several patents in organic ingredient production with global commercial product applications. The Company is focused on commercializing products utilizing its patented organic omega 3 DHA for products and processes. It is also focused on developing research and development (R&D) in protein expression, particularly as it relates to Bone Morphogenic Protein. Assessment of other areas of R&D will continue related to existing patents, including bio-hydrogen. The products produced using the Omega-3 DHA powder are produced without chemicals, solvents, and/or heavy processing that degrade the nutritional benefits. This preservation of the natural triglyceride form of the Omega-3 oils provides a pure and bioavailable health product. It offers a plant-based and sustainable product while avoiding ocean-based toxins/pollutants or residual processing solvents. It has produced Bone Morphogenetic Protein (BMP) in micro algae.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20257/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President MichaelFarley 11/1/2023 11/1/2023
Chief Financial Officer LeslieAuld 10/30/2023 1/30/2023
Director PaulLipoth 10/8/2024 10/8/2024

Business Names
Business Name
GCH Capital Partners Inc.
Phyco Hydrogen Inc.
Phycobiologics (Europe) Limited
4 additional Business Names available in full report.

General Information
Outstanding Shares: 60,755,372 (As of 1/31/2025)
Stock Exchange: NEX
Fax Number: (604) 239-0728


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, May 13, 2025